|
|
Volumn 71, Issue 1, 2001, Pages 238-242
|
|
Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LEXIPAFANT;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
ADULT;
AGED;
ARTICLE;
BLOOD SAMPLING;
BODY SURFACE;
CARBON DIOXIDE TENSION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
DOSE RESPONSE;
DRUG EFFECT;
FEMALE;
HEART SURGERY;
HUMAN;
LUNG FUNCTION;
LUNG INJURY;
LUNG VASCULAR RESISTANCE;
LUNG VENTILATION;
MAJOR CLINICAL STUDY;
MALE;
MEDIATOR RELEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
CORONARY ARTERY BYPASS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
IMIDAZOLES;
LEUCINE;
LUNG;
MALE;
MIDDLE AGED;
PLATELET ACTIVATING FACTOR;
RESPIRATORY INSUFFICIENCY;
|
|
EID: 0035138142
PISSN: 00034975
EISSN: None
Source Type: Journal
DOI: 10.1016/S0003-4975(00)01671-4 Document Type: Article |
|
Times cited : (7)
|
|
References (21)
|
